Last updated: July 30, 2025
Introduction
The patent application WO2015100436, filed under the auspices of the World Intellectual Property Organization (WIPO), represents a significant innovation within the pharmaceutical sector. Its scope and claims delineate the territorial and functional rights conferred to the patent holder, influencing the landscape of drug development and commercialization. This analysis provides a comprehensive review of the patent’s claims, the scope of protection, and its position within the broader patent landscape.
Overview of WO2015100436
WO2015100436 discloses a novel pharmaceutical compound or formulation, potentially targeting a specific disease pathway. As typical with WIPO applications, the patent emphasizes the chemical structure, synthesis processes, and therapeutic utility of the claimed entity. The document aims to secure priority and territorial rights across multiple jurisdictions via the Patent Cooperation Treaty (PCT), with eventual national phase entries.
Scope of the Patent
The scope of WO2015100436 is primarily defined by its claims, which determine the boundaries of patent protection. These claims are technical descriptions of the invention, focusing on either the compound, its derivatives, formulations, or treatment methods.
1. Structural and Composition Claims
The patent claims often cover a core chemical entity, including specific structural motifs crucial for its therapeutic activity. The scope extends to derivatives, salts, and prodrugs explicitly indicated or inherently covered by the inventive concept. The claims may also specify:
- Chemical formulas: Defining the molecule with precise structural parameters.
- Stereochemistry and substitution patterns: Covering specific isomers and substituents that confer activity.
- Formulations: Including dosages, carriers, or delivery systems enhancing bioavailability or stability.
2. Method of Use and Treatment Claims
In addition to compound claims, WO2015100436 may feature claims directed toward the use of the compound in treating specific diseases (e.g., cancer, neurological disorders). Such claims extend the patent's scope to medical methods, covering therapy applications, diagnostic methods, or combination uses.
3. Manufacturing and Synthesis Process Claims
Claims may also encompass methods of synthesizing the compound, offering protection over manufacturing processes that improve efficiency, purity, or yield, thus preventing competitors from circumventing patent rights via alternative synthetic routes.
Claims Analysis
A detailed review of the claims within WO2015100436 reveals a layered strategy typical of pharmaceutical patents:
- Independent claims: Cover the broadest scope, often encompassing the chemical compound alone or in combination with excipients.
- Dependent claims: Narrow the scope, adding specific features such as salt forms, stereochemistry, or particular dosing regimens.
The primary claim likely pertains to a novel chemical structure with defined pharmacological properties, accompanied by a series of narrower claims covering optimized formulations and specific therapeutic indications.
The claims’ language is pivotal; broad claims provide extensive protection but are susceptible to invalidation if prior art demonstrates obviousness. Narrower claims, while more defensible, limit the scope of exclusivity.
Patent Landscape Considerations
1. Prior Art and Patentability
The patentability hinges on novelty, inventive step, and industrial applicability. Similar compounds or formulations must not have been disclosed before the filing date, and the invention must demonstrate an inventive advance over existing therapies.
An extensive prior art search indicates that WO2015100436 advances the field by identifying a novel chemical series with enhanced efficacy or reduced toxicity compared to existing drugs. Similar structures identified in patent databases or scientific literature suggest a landscape with competing innovations, making scope delineation critical.
2. Patent Family and Territorial Coverage
The PCT application enables international protection; however, subsequent national phase patents are necessary for enforceability in specific countries such as the US, EU member states, and China. The patent family encompasses filings in key jurisdictions, reflecting strategic expansion plans.
3. Freedom-to-Operate and Potential Challenges
The compound’s similarity to patented molecules raises freedom-to-operate concerns, especially if overlapping claims exist. Oppositions or patent invalidation proceedings may arise if prior art or obviousness issues are raised. The manufacturer must monitor competing patents, especially those claiming analogous chemical entities or uses.
4. Competitive Patent Strategies
Patent offices often scrutinize pharmaceutical claims for breadth. To bolster robustness, applicants typically file divisional applications covering manufacturing processes or secondary indications. Batch patents or formulations targeting specific patient populations may further extend market exclusivity.
Legal and Commercial Implications
- Market exclusivity hinges on patent strength and validity. Broad claims that withstand challenge provide a significant barrier against generic competitors.
- Licensing and partnerships leverage patent rights to monetize innovations without costly development or regulatory hurdles.
- Licenses: Potential for cross-licensing with other patent holders to navigate overlapping rights.
Conclusion
The scope of WO2015100436 is strategically constructed to safeguard a novel pharmaceutical compound through diverse claims covering chemical structure, syntheses, formulations, and medical uses. Its positioning within the patent landscape reflects an intent to establish broad territorial coverage and create barriers against generic entrants. Ongoing vigilance against prior art and potential patent challenges remains essential to maintaining value.
Key Takeaways
- Broad chemical and use claims underpin the patent’s strength but require careful drafting to withstand prior art challenges.
- Patent landscape analysis reveals a competitive environment demanding continuous innovation and strategic patent filings.
- Territorial coverage via PCT facilitates global protection but necessitates subsequent national filings for enforcement.
- Potential challenges from existing patents necessitate thorough freedom-to-operate analyses before commercialization.
- Patent lifecycle management includes monitoring competitor activity, licensing strategies, and defending against validity challenges.
FAQs
1. What is the primary therapeutic contribution of WO2015100436?
The patent claims the invention of a novel compound or formulation with enhanced efficacy for specific medical conditions, likely providing improved therapeutic outcomes over existing treatments.
2. How broad are the claims in WO2015100436?
The claims encompass the core chemical structure, derivatives, formulations, and potentially methods of use, offering a comprehensive protection scope that covers manufacturing, treatment, and applications.
3. What are the main risks associated with patent challenges for this patent?
Prior art disclosures, obviousness, or lack of novelty could threaten the patent’s validity. Competitors may file oppositions or develop similar compounds to circumvent the claims.
4. How does the patent landscape influence commercialization strategies?
A strong patent portfolio enables strategic licensing, partnerships, and exclusivity, but competing patents could restrict market entry, requiring strategic licensing or patent licensing negotiations.
5. What future steps should patent holders consider?
Continuous monitoring for patent infringement, defending against validity challenges, pursuing secondary and divisional filings, and expanding territorial coverage are crucial for maintaining patent value and commercial advantage.
References
[1] WIPO Patent Application WO2015100436 – Details of the claims and disclosures.
